American Research & Management Company’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $798K | Sell |
3,539
-40
| -1% | -$9.7K | 0.22% | 72 |
|
|
2022
Q2 | $871K | Sell |
3,579
-572
| -14% | -$140K | 0.22% | 74 |
|
|
2022
Q1 | $1M | Hold |
4,151
| – | – | 0.22% | 69 |
|
|
2021
Q4 | $934K | Sell |
4,151
-75
| -2% | -$15.8K | 0.2% | 72 |
|
|
2021
Q3 | $899K | Sell |
4,226
-75
| -2% | -$17.3K | 0.21% | 71 |
|
|
2021
Q2 | $1.05M | Sell |
4,301
-364
| -8% | -$89.5K | 0.24% | 67 |
|
|
2021
Q1 | $1.16M | Sell |
4,665
-125
| -3% | -$29.8K | 0.28% | 67 |
|
|
2020
Q4 | $1.1M | Buy |
4,790
+125
| +3% | +$28.8K | 0.29% | 65 |
|
|
2020
Q3 | $1.19M | Buy |
4,665
+55
| +1% | +$13.6K | 0.35% | 61 |
|
|
2020
Q2 | $1.09M | Buy |
4,610
+16
| +0.3% | +$3.65K | 0.33% | 62 |
|
|
2020
Q1 | $931K | Hold |
4,594
| – | – | 0.35% | 62 |
|
|
2019
Q4 | $1.11M | Hold |
4,594
| – | – | 0.33% | 60 |
|
|
2019
Q3 | $889K | Sell |
4,594
-170
| -4% | -$32.6K | 0.27% | 75 |
|
|
2019
Q2 | $878K | Sell |
4,764
-1,000
| -17% | -$179K | 0.26% | 78 |
|
|
2019
Q1 | $1.09M | Buy |
5,764
+1,000
| +21% | +$191K | 0.31% | 68 |
|
|
2018
Q4 | $927K | Buy |
4,764
+87
| +2% | +$17K | 0.31% | 70 |
|
|
2018
Q3 | $969K | Hold |
4,677
| – | – | 0.29% | 69 |
|
|
2018
Q2 | $863K | Sell |
4,677
-200
| -4% | -$35.4K | 0.3% | 66 |
|
|
2018
Q1 | $831K | Sell |
4,877
-75
| -2% | -$13.8K | 0.27% | 74 |
|
|
2017
Q4 | $861K | Buy |
4,952
+100
| +2% | +$17.7K | 0.27% | 75 |
|
|
2017
Q3 | $905K | Sell |
4,852
-90
| -2% | -$15.9K | 0.29% | 69 |
|
|
2017
Q2 | $851K | Sell |
4,942
-185
| -4% | -$30.1K | 0.28% | 70 |
|
|
2017
Q1 | $841K | Sell |
5,127
-187
| -4% | -$31.1K | 0.3% | 60 |
|
|
2016
Q4 | $777K | Sell |
5,314
-250
| -4% | -$37.6K | 0.27% | 67 |
|
|
2016
Q3 | $928K | Sell |
5,564
-180
| -3% | -$30.4K | 0.34% | 61 |
|
|
2016
Q2 | $874K | Sell |
5,744
-135
| -2% | -$21K | 0.34% | 62 |
|
|
2016
Q1 | $881K | Sell |
5,879
-175
| -3% | -$26K | 0.37% | 62 |
|
|
2015
Q4 | $983K | Sell |
6,054
-325
| -5% | -$51.1K | 0.42% | 61 |
|
|
2015
Q3 | $882K | Buy |
6,379
+400
| +7% | +$63.1K | 0.39% | 64 |
|
|
2015
Q2 | $918K | Buy |
5,979
+245
| +4% | +$39.2K | 0.37% | 64 |
|
|
2015
Q1 | $917K | Sell |
5,734
-990
| -15% | -$156K | 0.37% | 63 |
|
|
2014
Q4 | $1.07M | Sell |
6,724
-175
| -3% | -$27.3K | 0.4% | 60 |
|
|
2014
Q3 | $969K | Hold |
6,899
| – | – | 0.35% | 64 |
|
|
2014
Q2 | $817K | Sell |
6,899
-350
| -5% | -$40.5K | 0.28% | 69 |
|
|
2014
Q1 | $894K | Sell |
7,249
-235
| -3% | -$28.5K | 0.32% | 67 |
|
|
2013
Q4 | $854K | Sell |
7,484
-100
| -1% | -$11.4K | 0.3% | 68 |
|
|
2013
Q3 | $849K | Sell |
7,584
-301
| -4% | -$32.6K | 0.34% | 67 |
|
|
2013
Q2 | $778K | Buy |
+7,885
| New | +$818K | 0.31% | 72 |
|
Other funds holding AMGN
American Research & Management Company's AMGN Position: Q3 2022 in Review
American Research & Management Company reduced its Amgen (AMGN) stake by 1.1% in Q3 2022, selling an estimated $9.7K and leaving 3,539 shares worth $798K. The position accounts for 0.22% of the portfolio, ranked #72.
American Research & Management Company first reported a position in AMGN in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.19M in Q3 2020. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- American Research & Management Company held 3,539 shares of Amgen worth $798K as of Q3 2022.
- American Research & Management Company sold 40 Amgen shares in Q3 2022, an estimated $9.7K.
- Amgen made up 0.22% of American Research & Management Company's portfolio in Q3 2022, its #72 holding.
- American Research & Management Company first reported a position in Amgen in Q2 2013 and has held it in 38 quarters since.
- American Research & Management Company's Amgen position peaked at $1.19M in Q3 2020.
- 2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.